Toth Financial Advisory Corp Has $2.47 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Toth Financial Advisory Corp lifted its holdings in The Clorox Company (NYSE:CLX - Free Report) by 36.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 15,177 shares of the company's stock after purchasing an additional 4,074 shares during the quarter. Toth Financial Advisory Corp's holdings in Clorox were worth $2,465,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. State Street Corp raised its position in Clorox by 3.1% in the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company's stock valued at $1,332,947,000 after buying an additional 245,525 shares during the last quarter. Mizuho Securities USA LLC raised its holdings in shares of Clorox by 46,877.8% in the third quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company's stock valued at $733,095,000 after purchasing an additional 4,490,421 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Clorox by 1.1% in the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company's stock worth $491,713,000 after purchasing an additional 33,970 shares in the last quarter. Stifel Financial Corp boosted its holdings in Clorox by 1.7% during the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company's stock worth $380,370,000 after purchasing an additional 37,967 shares during the last quarter. Finally, Van ECK Associates Corp grew its position in Clorox by 2.2% in the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company's stock valued at $237,372,000 after purchasing an additional 31,510 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have commented on CLX shares. TD Cowen raised shares of Clorox from a "sell" rating to a "hold" rating and boosted their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. JPMorgan Chase & Co. increased their price target on Clorox from $167.00 to $171.00 and gave the company a "neutral" rating in a research report on Thursday, January 16th. Wells Fargo & Company upgraded Clorox from an "underweight" rating to an "equal weight" rating and raised their price target for the company from $155.00 to $157.00 in a research note on Tuesday, January 7th. Jefferies Financial Group upgraded Clorox from a "hold" rating to a "buy" rating and upped their price objective for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Finally, Evercore ISI decreased their target price on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a research note on Monday, October 14th. Four equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $156.54.

Clorox Stock Performance

CLX stock traded down $1.71 during mid-day trading on Friday, hitting $159.12. 948,374 shares of the company were exchanged, compared to its average volume of 787,854. The Clorox Company has a 1-year low of $127.60 and a 1-year high of $171.37. The stock has a market capitalization of $19.70 billion, a PE ratio of 55.44, a price-to-earnings-growth ratio of 2.92 and a beta of 0.42. The business has a 50 day simple moving average of $163.66 and a 200-day simple moving average of $157.32. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX - Get Free Report) last released its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.50. The business had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm's quarterly revenue was up 27.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.49 EPS. On average, equities analysts forecast that The Clorox Company will post 6.87 earnings per share for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.07%. The ex-dividend date is Wednesday, January 29th. Clorox's dividend payout ratio is 170.04%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.